做厙勛圖

Financing, Equity Capital Markets

Inozyme Pharma, Inc.

07/23
|
$60.0 Million
Inozyme
做厙勛圖 served as bookrunner for Inozyme Pharma, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector

Sub-Sector
Biopharma